283 related articles for article (PubMed ID: 27485440)
1. Role of bioactive fatty acids in nonalcoholic fatty liver disease.
Juárez-Hernández E; Chávez-Tapia NC; Uribe M; Barbero-Becerra VJ
Nutr J; 2016 Aug; 15(1):72. PubMed ID: 27485440
[TBL] [Abstract][Full Text] [Related]
2. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review.
Galli C; Calder PC
Ann Nutr Metab; 2009; 55(1-3):123-39. PubMed ID: 19752539
[No Abstract] [Full Text] [Related]
3. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
Scorletti E; Byrne CD
Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids in mountain gorilla diets: implications for primate nutrition and health.
Reiner WB; Petzinger C; Power ML; Hyeroba D; Rothman JM
Am J Primatol; 2014 Mar; 76(3):281-8. PubMed ID: 24243235
[TBL] [Abstract][Full Text] [Related]
6. What are the health effects of fat?
Wahrburg U
Eur J Nutr; 2004 Mar; 43 Suppl 1():I/6-11. PubMed ID: 15052493
[TBL] [Abstract][Full Text] [Related]
7. Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil.
Morrison MC; Mulder P; Stavro PM; Suárez M; Arola-Arnal A; van Duyvenvoorde W; Kooistra T; Wielinga PY; Kleemann R
PLoS One; 2015; 10(9):e0139196. PubMed ID: 26405765
[TBL] [Abstract][Full Text] [Related]
8. Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients.
López-Bautista F; Barbero-Becerra VJ; Ríos MY; Ramírez-Cisneros MÁ; Sánchez-Pérez CA; Ramos-Ostos MH; Uribe M; Chávez-Tapia NC; Juárez-Hernández E
Ann Hepatol; 2020; 19(5):482-488. PubMed ID: 32717363
[TBL] [Abstract][Full Text] [Related]
9. Food for New Zealanders.
Shorland FB
N Z Med J; 1993 Oct; 106(965):436-7. PubMed ID: 8292167
[No Abstract] [Full Text] [Related]
10. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
Scorletti E; Byrne CD
Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
[TBL] [Abstract][Full Text] [Related]
11. Steatosis and collagen content in experimental liver cirrhosis are affected by dietary monounsaturated and polyunsaturated fatty acids.
Fernández MI; Torres MI; Gil A; Ríos A
Scand J Gastroenterol; 1997 Apr; 32(4):350-6. PubMed ID: 9140157
[TBL] [Abstract][Full Text] [Related]
12. Dietary lipids and NAFLD: suggestions for improved nutrition.
Molendi-Coste O; Legry V; Leclercq IA
Acta Gastroenterol Belg; 2010; 73(4):431-6. PubMed ID: 21299150
[TBL] [Abstract][Full Text] [Related]
13. [A Future Perspective on the Involvement of n-3 Polyunsaturated Fatty Acid in the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis].
Nakamoto K; Obata T; Hirasawa A; Kim KI; Kim SR; Tokuyama S
Yakugaku Zasshi; 2016; 136(4):583-9. PubMed ID: 27040343
[TBL] [Abstract][Full Text] [Related]
14. Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy.
Shim P; Choi D; Park Y
Ann Nutr Metab; 2017; 70(4):303-311. PubMed ID: 28595185
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
16. Nutritional value of raw pork depending on the fat type contents in pigs feed.
Waszkiewicz-Robak B; Szterk A; Rogalski M; Rambuszek M; Kruk M; Rokowska E
Acta Sci Pol Technol Aliment; 2015; 14(2):153-163. PubMed ID: 28068013
[TBL] [Abstract][Full Text] [Related]
17. Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease.
Cansanção K; Silva Monteiro L; Carvalho Leite N; Dávalos A; Tavares do Carmo MDG; Arantes Ferreira Peres W
Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380656
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Hepatic Lipid Metabolism, and their Relation to Dietary Macronutrients in Pediatric Nonalcoholic Fatty Liver Disease.
St-Jules DE; Watters CA
Drug Metab Lett; 2015; 9(2):72-9. PubMed ID: 26343136
[TBL] [Abstract][Full Text] [Related]
19. Monounsaturated and omega-3 but not omega-6 polyunsaturated fatty acids improve hepatic fibrosis in hypercholesterolemic rabbits.
Aguilera CM; Ramirez-Tortosa CL; Quiles JL; Yago MD; Martínez-Burgos MA; Martínez-Victoria E; Gil A; Ramirez-Tortosa MC
Nutrition; 2005 Mar; 21(3):363-71. PubMed ID: 15797680
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV.
de Almeida CF; da Silva PS; Cardoso CSA; Moreira NG; Antunes JC; de Andrade MM; Silva J; Araujo MC; Peres WAF; do Brasil PEAA; Moreira RI; Cardoso SW; Veloso VG; Grinsztejn B; de Brito PD; Perazzo H
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
